Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
Clinical trial NCT03601819 · TERMINATED
Trial details
- NCT number
- NCT03601819
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2020-03-07
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.